Motus GI Holdings with ticker code (MOTS) have now 6 analysts covering the stock with the consensus suggesting a rating of ‘Strong_Buy’. The range between the high target price and low target price is between 3 and 2 calculating the mean target price we have 2.5. Now with the previous closing price of 0.97 this is indicating there is a potential upside of 157.7%. The 50 day moving average now sits at 0.9 and the 200 moving average now moves to 1.05. The market capitalisation for the company is $32m. You can visit the company’s website by visiting: http://www.motusgi.com
Motus GI Holdings, a medical technology company, provides endoscopy solutions that enhance clinical outcomes and the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions in the United States and Israel. Its flagship product is the Pure-Vu system, a medical device to facilitate the cleaning of a poorly prepared colon during the colonoscopy procedure. The company is based in Fort Lauderdale, Florida.